Most Recent
Vagisil maker wins appeal to halt European rival’s trade mark
The maker of Vagisil feminine hygiene products has successfully overturned a ruling that denied its bid to stop a European competitor from registering Vagisan as a trade mark in Australia.
Computer-implemented invention fails again to pass patent test
The Federal Court has once again sided with the Commissioner of Patents in a challenge to a ruling that patents for a computer-implemented invention did not describe a manner of manufacture and should be revoked.
Top 10 class action settlements of 2020
Payouts in class actions in 2020 largely kept pace with the previous year despite the financial strain of the COVID-19 pandemic, with companies and other defendants paying more than $696 million to settle class actions last year.
ASIC wins winding up orders against accused Ponzi schemer Chris Marco
A judge has ordered the winding up of a managed investment scheme operated by Perth businessman Chris Marco and his company AMS Holdings after investors allegedly lost more than $200 million.
Theta hit with $2M penalty for defective product disclosure statements
A court has ordered Theta Asset Management, a collapsed financial services provider that ran a property investment scheme targeting retirees, to pay a $2 million penalty for issuing defective product disclosure statements.
AIG settles case against ex-Kaboko Mining directors after D&O policy exclusion spat
AIG has settled a lawsuit brought by Kaboko Mining against several former directors alleging they failed to exploit commercial opportunities, after the insurer failed to convince an appeals court that an insolvency exclusion in the company's D&O policy should exempt it from covering the claims.
Proportionality no basis to deny fees in $7M QRxPharma class action settlement, judge says
A judge has approved a $7 million settlement in a class action against the directors of pharmaceutical company QRxPharma, only a third of which will go to group members, saying proportionality was not a basis for rejecting fees that were otherwise fair and reasonable.
Funder will take loss in $7M QRxPharma class action settlement
The funder backing a shareholder class action against the directors of pharmaceutical firm QRxPharma will not seek to profit from a $7 million settlement in order to bring about a better return for group members, a judge has been told.
QRx Pharma shareholders to get small slice of $7M class action settlement
A former QRx Pharma director's prediction that shareholders would not receive "anything of consequence" from a class action settlement has proven true, with only a small slice of the $7 million settlement expected to go to shareholders.
High Court awards businessman $27M over Securency ‘shabby fraud’
The High Court has awarded $27 million in unpaid commissions to a Nigerian entrepreneur tricked into terminating his contract with international bank note manufacturer Securency, reversing a Full Court judgment which slashed his award.